Stability of the HSV-2 US-6 Gene in the del II, del III, CP77, and I8R-G1L Sites in Modified Vaccinia Virus Ankara After Serial Passage of Recombinant Vectors in Cells.

Atukorale, Vajini N; Weir, Jerry P; Meseda, Clement A

Stability of the HSV-2 US-6 Gene in the del II, del III, CP77, and I8R-G1L Sites in Modified Vaccinia Virus Ankara After Serial Passage of Recombinant Vectors in Cells.

Atukorale, Vajini N; Weir, Jerry P; Meseda, Clement A.

Afiliação

Atukorale VN; Division of Viral Products, Center for Biologics Evaluation and Research, U S Food & Drug Administration, Silver Spring, MD 20993, USA.
Weir JP; Division of Viral Products, Center for Biologics Evaluation and Research, U S Food & Drug Administration, Silver Spring, MD 20993, USA.
Meseda CA; Division of Viral Products, Center for Biologics Evaluation and Research, U S Food & Drug Administration, Silver Spring, MD 20993, USA.

Vaccines (Basel) ; 8(1)2020 Mar 19.

Article em En | MEDLINE | ID: mdl-32204367

Palavras-chave

HSV-2; modified vaccinia virus Ankara; transgene; vaccine stability

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Vaccines (Basel) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google